FibroGen
A biopharmaceutical company focused on developing treatments for anemia, idiopathic pulmonary fibrosis, pancreatic cancer, Duchenne muscular dystrophy and corneal blindness
1
Funding Rounds
$6.0m
Money raised
Overview
A biopharmaceutical company focused on developing treatments for anemia, idiopathic pulmonary fibrosis, pancreatic cancer, Duchenne muscular dystrophy and corneal blindness
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company FibroGen has raised a total of $6.02m in funding over 1 rounds.
Key Insights:
- FibroGen funding round, July 2012: $6.02m
FibroGen funding round, July 2012
$6.02m
Industries
FibroGen is active in the following industries: